top of page
Eptinezumab: A Promising 60-Week Solution for Chronic Migraines
A recent study published in the Journal of Headache and Pain examined the long-term tolerability and effectiveness of eptinezumab in Japanese adults w...
MigraineMind
Nov 23, 20251 min read
Unlocking Migraine Relief: Tianshu Capsule's Polysaccharides Explained
Researchers have made strides in understanding how Tianshu Capsule (TSC), a traditional Chinese medicine, alleviates migraines. This study, published ...
MigraineMind
Nov 23, 20251 min read
Daily Research Roundup: 4 New Migraine Studies
Today's migraine research brings 4 important studies covering breakthrough treatments, new insights, and innovative approaches to migraine management....
MigraineMind
Nov 23, 20251 min read
Partial Rebreathing Fails to Relieve Migraine Aura Symptoms
A recent study published in the journal Headache investigated the effectiveness of a partial rebreathing device for treating migraines with aura. Cond...
MigraineMind
Nov 23, 20251 min read
Atogepant's Impact on Migraine Days: New Study Insights
A recent study published in CPT Pharmacometrics & Systems Pharmacology explored how different doses of atogepant impact monthly migraine days (MMD) in...
MigraineMind
Nov 23, 20251 min read
Eptinezumab: Long-Term Relief for Chronic Migraines in Japan
In the 60-week open-label SUNSET trial, published in J Headache Pain, researchers assessed the long-term tolerability and effectiveness of eptinezumab...
MigraineMind
Nov 23, 20251 min read
New Polysaccharide Shows Promise in Migraine Relief Study
A recent study published in Carbohydrate Polymers unveils the structural and pharmacokinetic properties of polysaccharides from the Tianshu Capsule (T...
MigraineMind
Nov 23, 20251 min read
bottom of page